• Arix Bioscience plc: Team changes firstwordpharma
    July 07, 2021
    Arix Bioscience plc (“Arix” or “the Company”) (LSE: ARIX), a global venture capital company focused on investing and building breakthrough biotech companies, today announces that Mark Chin will be re-joining the Arix investment team as a Managing Director
  • Merck to acquire oncology firm VelosBio for $2.75bn pharmaceutical-technology
    November 09, 2020
    Merck (MSD) has signed a definitive agreement to acquire all outstanding shares of Pappas Capital’s portfolio company VelosBio through a subsidiary for $2.75bn in cash, subject to certain customary adjustments.
PharmaSources Customer Service